Does anticoagulation (DOACs) benefit patients with subclinical atrial fibrillation?
Ongoing large-scale DOAC trials and patient-specific factors may help determine anticoagulation eligibility for subclinical atrial fibrillation.
, concomitant medications, blood pressure control) may help determine eligibility for anticoagulation. Ongoing large-scale DOAC trials will further clarify this contentious issue.
Pradhan et al. (Thu,) studied this question.